JP2021029202A - Spreader for feed, and solid feed on which medicine is spread by the same - Google Patents
Spreader for feed, and solid feed on which medicine is spread by the same Download PDFInfo
- Publication number
- JP2021029202A JP2021029202A JP2019155260A JP2019155260A JP2021029202A JP 2021029202 A JP2021029202 A JP 2021029202A JP 2019155260 A JP2019155260 A JP 2019155260A JP 2019155260 A JP2019155260 A JP 2019155260A JP 2021029202 A JP2021029202 A JP 2021029202A
- Authority
- JP
- Japan
- Prior art keywords
- feed
- starch syrup
- mass
- drug
- spread
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 133
- 239000007787 solid Substances 0.000 title claims abstract description 30
- 229920002472 Starch Polymers 0.000 claims abstract description 146
- 239000008107 starch Substances 0.000 claims abstract description 146
- 235000019698 starch Nutrition 0.000 claims abstract description 146
- 239000006188 syrup Substances 0.000 claims abstract description 143
- 235000020357 syrup Nutrition 0.000 claims abstract description 143
- 238000003892 spreading Methods 0.000 claims abstract description 116
- 239000000203 mixture Substances 0.000 claims abstract description 38
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 150000002016 disaccharides Chemical class 0.000 claims abstract description 12
- 150000002772 monosaccharides Chemical class 0.000 claims abstract description 12
- 150000004044 tetrasaccharides Chemical class 0.000 claims abstract description 12
- 150000004043 trisaccharides Chemical class 0.000 claims abstract description 12
- 229940079593 drug Drugs 0.000 claims description 129
- 239000003795 chemical substances by application Substances 0.000 claims description 64
- 235000000346 sugar Nutrition 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 12
- 229920002245 Dextrose equivalent Polymers 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 abstract description 18
- 230000002265 prevention Effects 0.000 abstract description 3
- 150000001720 carbohydrates Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 29
- 239000008188 pellet Substances 0.000 description 19
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 18
- 239000001768 carboxy methyl cellulose Substances 0.000 description 17
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 17
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 17
- 238000011156 evaluation Methods 0.000 description 16
- 239000000843 powder Substances 0.000 description 16
- 238000010828 elution Methods 0.000 description 12
- 229920002907 Guar gum Polymers 0.000 description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 11
- 239000000665 guar gum Substances 0.000 description 11
- 235000010417 guar gum Nutrition 0.000 description 11
- 229960002154 guar gum Drugs 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000004033 plastic Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 5
- 229960002477 riboflavin Drugs 0.000 description 5
- 235000019192 riboflavin Nutrition 0.000 description 5
- 239000002151 riboflavin Substances 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- -1 astaxanthin Chemical class 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
- 235000019345 sodium thiosulphate Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000251556 Chordata Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940126578 oral vaccine Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Landscapes
- Fodder In General (AREA)
Abstract
Description
本発明は、所定の還元水飴または水飴を有効成分とする飼料用展着剤、および、薬物が展着された固形飼料に関する。 The present invention relates to a predetermined reduced starch syrup or a feed spreading agent containing starch syrup as an active ingredient, and a solid feed on which a drug is spread.
動物に対して経口的に薬物を投与する場合、錠剤、粉体または溶液などの形態の薬物をそのまま投与するには、一般に、強制的な投与が必要となる。しかし、感染症の予防・治療目的などで多数の動物への一斉投与が必要な場合は、手間が多く実用的ではない。よって、このような場合は、薬物を混入あるいは表面に展着させた飼料を給餌する方法が採られている。 When administering a drug orally to an animal, compulsory administration is generally required to administer the drug in the form of tablets, powders or solutions as is. However, when simultaneous administration to a large number of animals is required for the purpose of prevention / treatment of infectious diseases, it is troublesome and impractical. Therefore, in such a case, a method of feeding a feed mixed with a drug or spread on the surface is adopted.
薬物を固形飼料の表面に展着させる際には、展着を容易あるいは強固にする等の目的で展着剤が用いられる場合が多い。展着剤としては、従来、カルボキシメチルセルロース(CMC)やグァーガム、アルギン酸ナトリウム、ポリアクリル酸ナトリウムなどの水溶性糊剤が用いられているほか、特許文献1には、炭素粉末を含有する動物飼料用展着剤が開示されている。 When spreading a drug on the surface of solid feed, a spreading agent is often used for the purpose of facilitating or strengthening the spreading. Conventionally, water-soluble pastes such as carboxymethyl cellulose (CMC), guar gum, sodium alginate, and sodium polyacrylate have been used as the spreading agent, and Patent Document 1 describes for animal feed containing carbon powder. Spreading agents are disclosed.
しかしながら、従来の展着剤は、薬物を飼料に均一に展着できず、薬物が多量に展着したものと少量しか展着していないものとが生じるという問題があった。すなわち、当該飼料を給餌した動物群では、個体間で薬物投与量の過不足が生じる懸念があった。また、展着力が不十分で薬物のロス(投与目的で使用された薬物のうち、投与されなかったもの)が多く生じるなどの問題もあった。この点、特許文献1の動物飼料用展着剤は、水中において薬物の溶出が無いことが記載されている(実施例1、実施例2)ものの、薬物を飼料に均一に展着できるかどうかは不明である。すなわち、これら先行技術を鑑みても、均一性と展着力とを兼ね備えた飼料用展着剤は十分に供給されている状況ではない。 However, the conventional spreading agent has a problem that the drug cannot be uniformly spread on the feed, and some drugs are spread in a large amount and some are spread only in a small amount. That is, in the animal group fed with the feed, there was a concern that excess or deficiency of drug dose would occur between individuals. In addition, there is also a problem that the spreading power is insufficient and a large amount of drug loss (drugs used for the purpose of administration but not administered) occurs. In this regard, although it is described that the spreading agent for animal feed of Patent Document 1 does not elute the drug in water (Examples 1 and 2), whether or not the drug can be uniformly spread on the feed. Is unknown. That is, even in view of these prior arts, the feed spreading agent having both uniformity and spreading power is not sufficiently supplied.
本発明は、係る課題を解決するためになされたものであって、高い均一性および高い展着力を備えた飼料用展着剤、および、これにより表面に薬物が展着された固形飼料を提供することを目的とする。 The present invention has been made to solve such a problem, and provides a feed spreading agent having high uniformity and high spreading force, and a solid feed in which a drug is spread on the surface thereof. The purpose is to do.
本発明者らは、鋭意研究の結果、単糖が1〜50質量%、二糖が6〜55質量%、三糖が7〜25質量%、四糖が1〜10質量%および五糖以上が1〜82質量%である糖組成からなる還元水飴もしくは水飴、または、デキストロース当量が14以上70以下の水飴もしくは当該水飴を還元してなる還元水飴が、飼料に薬物を均一に展着できることを見出した。また、前記還元水飴または前記水飴が、飼料に薬物を多量に展着できることを見出した。さらに、前記還元水飴または前記水飴が、水中においても優れた展着力を保持し、水中への薬物の溶出を抑制できることを見出した。そこで、これらの知見に基づいて、下記の各発明を完成した。 As a result of diligent research, the present inventors have found that monosaccharides are 1 to 50% by mass, disaccharides are 6 to 55% by mass, trisaccharides are 7 to 25% by mass, tetrasaccharides are 1 to 10% by mass, and pentasaccharides or more. The reduced starch syrup or starch syrup having a sugar composition of 1 to 82% by mass, or the starch syrup having a dextrose equivalent of 14 or more and 70 or less, or the reduced starch syrup obtained by reducing the starch syrup can uniformly spread the drug on the feed. I found it. It has also been found that the reduced starch syrup or the starch syrup can spread a large amount of a drug on the feed. Furthermore, it has been found that the reduced starch syrup or the starch syrup can maintain excellent spreading power even in water and suppress the elution of the drug into water. Therefore, based on these findings, the following inventions have been completed.
(1)本発明に係る飼料用展着剤の第1の態様は、下記の糖組成の還元水飴または下記の糖組成の水飴を有効成分とする;
単糖が1〜50質量%、
二糖が6〜55質量%、
三糖が7〜25質量%、
四糖が1〜10質量%、
五糖以上が1〜82質量%。
(1) The first aspect of the feed spreading agent according to the present invention comprises a reduced starch syrup having the following sugar composition or a starch syrup having the following sugar composition as an active ingredient;
1 to 50% by mass of monosaccharides,
Disaccharide is 6-55% by mass,
7-25% by mass of trisaccharide,
1-10% by mass of tetrasaccharide,
1-82% by mass of pentasaccharide or more.
(2)本発明に係る飼料用展着剤の第2の態様は、デキストロース当量が14以上70以下の水飴または前記水飴を還元してなる還元水飴を有効成分とする。 (2) In the second aspect of the feed spreading agent according to the present invention, a starch syrup having a dextrose equivalent of 14 or more and 70 or less or a reduced starch syrup obtained by reducing the starch syrup is used as an active ingredient.
(3)本発明に係る飼料用展着剤の有効成分は、還元水飴または水飴を固形分濃度50質量%以上で含有する液体であってもよい。 (3) The active ingredient of the spreader for feed according to the present invention may be a reduced starch syrup or a liquid containing starch syrup at a solid content concentration of 50% by mass or more.
(4)本発明において、還元水飴または水飴の糖組成は、下記のものであってもよい;
単糖が1〜10質量%、
二糖が6〜12質量%、
三糖が7〜12質量%、
四糖が5〜10質量%、
五糖以上が64〜82質量%。
(4) In the present invention, the reduced starch syrup or the sugar composition of starch syrup may be as follows;
1-10% by mass of monosaccharides,
6-12% by mass of disaccharide,
7-12% by mass of trisaccharide,
5-10% by mass of tetrasaccharide,
64-82% by mass of pentasaccharide or more.
(5)本発明に係る固形飼料は、本発明に係る飼料用展着剤によって表面に薬物が展着された固形飼料である。 (5) The solid feed according to the present invention is a solid feed in which a drug is spread on the surface by the feed spreading agent according to the present invention.
本発明によれば、飼料に薬物を均一に展着することができる。よって、当該飼料を給餌する動物群において、薬物投与量の過不足の防止ないし均等化に寄与することができる。また、薬物を飼料に展着させる際に比較的多量に展着できる。また、本発明により薬物を展着した飼料を水中や水上で用いた場合でも、展着した薬物の溶出を抑制できる。これらのことから、薬効の担保や薬物のロスの低減に寄与することができる。 According to the present invention, the drug can be uniformly spread on the feed. Therefore, it is possible to contribute to the prevention or equalization of excess or deficiency of drug dose in the animal group to which the feed is fed. In addition, when the drug is spread on the feed, it can be spread in a relatively large amount. Further, according to the present invention, even when the feed on which the drug is spread is used in water or water, the elution of the spread drug can be suppressed. From these facts, it is possible to contribute to guaranteeing drug efficacy and reducing drug loss.
以下、本発明について詳細に説明する。本発明に係る飼料用展着剤は、下記の還元水飴または水飴を有効成分とする:
第1の態様;単糖が1〜50質量%、二糖が6〜55質量%、三糖が7〜25質量%、四糖が1〜10質量%および五糖以上が1〜82質量%の糖組成である還元水飴、または、左記の糖組成である水飴。
第2の態様;デキストロース当量が14以上70以下の水飴、または、左記の水飴を還元してなる還元水飴。
Hereinafter, the present invention will be described in detail. The feed spreading agent according to the present invention contains the following reduced starch syrup or starch syrup as an active ingredient:
First embodiment: 1 to 50% by mass of monosaccharides, 6 to 55% by mass of disaccharides, 7 to 25% by mass of trisaccharides, 1 to 10% by mass of tetrasaccharides and 1 to 82% by mass of pentasaccharides or more. The reduced water candy having the sugar composition of, or the water candy having the sugar composition shown on the left.
Second aspect; starch syrup having a dextrose equivalent of 14 or more and 70 or less, or reduced starch syrup obtained by reducing the starch syrup shown on the left.
本発明において、「飼料に薬物が展着する」とは、飼料の表面の全体または一部に薬物が付着することを意味する。 In the present invention, "the drug spreads on the feed" means that the drug adheres to the whole or a part of the surface of the feed.
本発明において、飼料用展着剤とは、飼料への薬物の付着を容易にするため、媒介的に用いられる組成物をいう。 In the present invention, the spreader for feed refers to a composition used as an intermediary in order to facilitate the adhesion of a drug to feed.
本発明において、薬物は、動物の疾病ないし病的症状の治療または予防作用を有する化合物(いわゆる動物用医薬品)のほか、飼料の品質保持、飼料が含有している栄養成分の有効な利用の促進、栄養補給、外見向上等の作用を有し、飼料に加えて追加的に摂取させる化合物も含む。具体的には、抗生物質、ホルモン剤、経口ワクチン、生理活性物質、合成抗菌剤、ビタミン類やアミノ酸類、ミネラル、アスタキサンチンなどの色素、栄養剤、着香料、呈味料、酵素、生菌剤、有機酸、抗酸化剤、防カビ剤、粘結剤、乳化剤、調整剤などを例示することができる。薬物は1種からなるものであってもよく、複数種からなるものであってもよい。薬物の形態としては、粉末や顆粒などの粉粒体が例示される。 In the present invention, the drug is a compound having a therapeutic or preventive effect on an animal disease or pathological symptom (so-called veterinary drug), as well as maintaining the quality of feed and promoting effective utilization of nutritional components contained in the feed. It also contains compounds that have the effects of nutritional supplementation, appearance improvement, etc., and are additionally ingested in addition to feed. Specifically, antibiotics, hormones, oral vaccines, physiologically active substances, synthetic antibacterial agents, vitamins and amino acids, minerals, pigments such as astaxanthin, nutritional supplements, flavoring agents, flavoring agents, enzymes, viable bacteria agents , Organic acids, antioxidants, antifungal agents, binders, emulsifiers, modifiers and the like can be exemplified. The drug may consist of one type or a plurality of types. Examples of the form of the drug include powders and granules.
本発明において、飼料は、動物に餌として与えられる物をいう。飼料の形態は、その表面に薬物が展着されうる固形飼料であれば良く、飼料の大きさや形状、組成は給餌対象の動物種や月齢等に応じて、適宜設定することができる。飼料の形状として、具体的には、粉末や顆粒、クランブル、ペレット、フレークなどを例示することができる。 In the present invention, the feed refers to a product fed to an animal as food. The form of the feed may be any solid feed on which the drug can be spread, and the size, shape, and composition of the feed can be appropriately set according to the animal species to be fed, the age of the moon, and the like. Specific examples of the shape of the feed include powder, granules, crumbles, pellets, and flakes.
ここで、飼料の給餌対象の動物は、ヒト以外の任意の動物をいい、飼育動物であってもよく、野生動物であってもよい。飼育動物である場合、畜産・水産等の食用、愛玩用、観賞・展示用、実験用などの飼育目的は問わない。動物種として、具体的には、脊索動物や脊椎動物、軟体動物、節足動物が例示され、より具体的には、魚類、両生類、甲殻類、ほ乳類、鳥類、貝類などが例示される。 Here, the animal to be fed with the feed refers to any animal other than humans, and may be a domestic animal or a wild animal. In the case of domestic animals, the purpose of breeding is not limited, such as for food such as livestock and fisheries, for pets, for ornamental / exhibition, and for experiments. Specific examples of animal species include chordates, vertebrates, mollusks, and arthropods, and more specific examples include fish, amphibians, crustaceans, mammals, birds, and shellfish.
飼料が、魚類や甲殻類あるいは魚介類などの水生動物の飼料である場合、本発明では、薬物を展着した飼料を水中や水上で用いた場合でも、展着した薬物の溶出を抑制できるという特有の効果を発揮する。すなわち、飼料の好ましい1態様は、水産飼料などの固形水生動物飼料である。 When the feed is a feed for aquatic animals such as fish, crustaceans, and seafood, the present invention states that even when the feed on which the drug is spread is used in water or water, the elution of the spread drug can be suppressed. Demonstrate a unique effect. That is, one preferred embodiment of the feed is a solid aquatic animal feed such as aquatic feed.
水飴は、デンプンを酸や酵素などで糖化して得られる物質であり、単糖(ブドウ糖)および多糖(オリゴ糖やデキストリンなど)の混合物である。還元水飴は、水飴を還元して得られる糖アルコールの一種である。よって、還元水飴もまた、単糖の糖アルコールおよび多糖(二糖、三糖、四糖または五糖以上)の糖アルコールのうち、2種以上の糖アルコールを含む混合物である。 Syrup is a substance obtained by saccharifying starch with an acid or an enzyme, and is a mixture of monosaccharide (glucose) and polysaccharide (oligosaccharide, dextrin, etc.). Reduced starch syrup is a type of sugar alcohol obtained by reducing starch syrup. Therefore, reduced starch syrup is also a mixture containing two or more sugar alcohols among monosaccharide sugar alcohols and polysaccharide sugar alcohols (disaccharides, trisaccharides, tetrasaccharides or pentasaccharides or more).
本発明において、糖組成とは、糖の総質量に占める各糖の質量割合を百分率で示すものをいう。すなわち、糖の総質量を100とした場合の、各糖の質量百分率である。 In the present invention, the sugar composition refers to a percentage indicating the mass ratio of each sugar to the total mass of sugars. That is, it is the mass percentage of each sugar when the total mass of sugars is 100.
本発明に係る飼料用展着剤の第1の態様において、還元水飴または水飴の糖組成は、単糖が1〜50質量%、二糖が6〜55質量%、三糖が7〜25質量%、四糖が1〜10質量%および五糖以上が1〜82質量%である。係る糖組成のうち、飼料における薬物展着の均一性をより向上させる観点、薬物の展着量をより向上させる観点、あるいは薬物の溶出量をより抑制する観点からは、単糖が1〜10質量%、二糖が6〜55質量%、三糖が7〜25質量%、四糖が1〜10質量%および五糖以上が5〜82質量%の糖組成、あるいは、単糖が1〜10質量%、二糖が6〜21質量%、三糖が7〜16質量%、四糖が5〜10質量%および五糖以上が51〜82質量%の糖組成、あるいは単糖が1〜10質量%、二糖が6〜12質量%、三糖が7〜12質量%、四糖が5〜10質量%および五糖以上が64〜82質量%の糖組成としてもよい。 In the first aspect of the feed spreading agent according to the present invention, the sugar composition of the reduced water candy or water candy is 1 to 50% by mass of monosaccharide, 6 to 55% by mass of disaccharide, and 7 to 25% by mass of trisaccharide. %, Tetrasaccharide is 1 to 10% by mass, and pentasaccharide or more is 1 to 82% by mass. Among the sugar compositions, monosaccharides are 1 to 10 from the viewpoint of further improving the uniformity of drug spread in the feed, further improving the spread amount of the drug, or further suppressing the elution amount of the drug. Sugar composition of 6 to 55% by mass of disaccharide, 7 to 25% by mass of trisaccharide, 1 to 10% by mass of tetrasaccharide and 5 to 82% by mass of pentasaccharide or more, or 1 to 1 by mass of monosaccharide Sugar composition of 10% by mass, 6 to 21% by mass of disaccharide, 7 to 16% by mass of trisaccharide, 5 to 10% by mass of tetrasaccharide and 51 to 82% by mass of pentasaccharide or more, or 1 to 1 by monosaccharide. The sugar composition may be 10% by mass, 6 to 12% by mass of disaccharide, 7 to 12% by mass of trisaccharide, 5 to 10% by mass of tetrasaccharide, and 64 to 82% by mass of pentasaccharide or more.
糖組成は、高速液体クロマトグラフィー(HPLC)を用いて確認することができる。すなわち、還元水飴や水飴を試料としてHPLCに供してクロマトグラムを得る。当該クロマトグラムにおいて、全ピークの面積の総和が「糖の総質量」に、各ピークの面積が「各糖の質量」に相当する。よって、試料における各糖の質量百分率は、検出された全ピークの面積の総和に対する各ピークの面積の割合として算出することができる。HPLCの条件は、定法に従って適宜設定することができるが、下記条件を例示することができる。
《HPLCの条件》
カラム;MCI GEL CK04S(10mm ID x 200mm)
溶離液;高純水
流速;0.4mL/分
注入量;20μL
カラム温度;65℃
検出;示差屈折率検出器RI-10A(島津製作所)
The sugar composition can be confirmed using high performance liquid chromatography (HPLC). That is, a chromatogram is obtained by subjecting reduced starch syrup or starch syrup to HPLC as a sample. In the chromatogram, the total area of all peaks corresponds to "total mass of sugars" and the area of each peak corresponds to "mass of each sugar". Therefore, the mass percentage of each sugar in the sample can be calculated as the ratio of the area of each peak to the total area of all the detected peaks. The HPLC conditions can be appropriately set according to a conventional method, and the following conditions can be exemplified.
<< HPLC conditions >>
Column; MCI GEL CK04S (10mm ID x 200mm)
Eluent; high pure water flow rate; 0.4 mL / min injection volume; 20 μL
Column temperature; 65 ° C
Detection: Differential refractive index detector RI-10A (Shimadzu Corporation)
水飴の糖化の程度の指標は、一般に、デキストロース当量(Dextrose Equivalent値;DE)が用いられる。DEは、試料中の還元糖をブドウ糖として測定したときの、当該還元糖の全固形分に対する割合(百分率)である。DEの最大値は100で、固形分の全てがブドウ糖であることを意味し、DEが小さくなるほど少糖類や多糖類が多いことを意味する。 Dextrose equivalent (Dextrose Equivalent value; DE) is generally used as an index of the degree of saccharification of starch syrup. DE is the ratio (percentage) of the reducing sugar to the total solid content when the reducing sugar in the sample is measured as glucose. The maximum value of DE is 100, which means that all of the solids are glucose, and the smaller the DE, the more oligosaccharides and polysaccharides.
本発明に係る飼料用展着剤の第2の態様において、有効成分を水飴とする場合、その水飴のDEは14以上70以下である。あるいは、有効成分を還元水飴とする場合、その還元水飴は、DEが14以上70以下の水飴を還元してなる還元水飴である。飼料における薬物展着の均一性をより向上させる観点、薬物の展着量をより向上させる観点、あるいは薬物の溶出量をより抑制する観点からは、DEが、14以上37以下、14以上30以下あるいは14以上16以下の水飴またはその還元物を有効成分としてもよい。 In the second aspect of the feed spreading agent according to the present invention, when the active ingredient is starch syrup, the DE of the starch syrup is 14 or more and 70 or less. Alternatively, when the active ingredient is reduced starch syrup, the reduced starch syrup is a reduced starch syrup obtained by reducing starch syrup having a DE of 14 or more and 70 or less. From the viewpoint of further improving the uniformity of drug spread in the feed, further improving the spread amount of the drug, or further suppressing the elution amount of the drug, the DE is 14 or more and 37 or less, 14 or more and 30 or less. Alternatively, starch syrup of 14 or more and 16 or less or a reduced product thereof may be used as an active ingredient.
なお、水飴のDEは、下記の方法により測定することができる。
《DEの測定方法》
試料2.5gを正確に量り、水で溶かして200mLとする。この液10mLを量り、1/25mol/L ヨウ素溶液(注1)10mLと1/25mol/L 水酸化ナトリウム溶液(注2)15mLを加えて20分間暗所に放置する。次に、2mol/L塩酸(注3)を5mL加えて混和した後、1/25mol/L チオ硫酸ナトリウム溶液(注4)で滴定する。滴定の終点近くで液が微黄色になったら、デンプン指示薬(注5)2滴を加えて滴定を継続し、液の色が消失した時点を滴定の終点とする。水を用いてブランク値を求め、次式1によりDEを求める。
(注1)1/25mol/L ヨウ素溶液:ヨウ化カリウム20.4gとヨウ素10.2gを2Lのメスフラスコに入れ、少量の水で溶解後、標線まで水を加える。
(注2)1/25mol/L 水酸化ナトリウム溶液:水酸化ナトリウム3.2gを2Lのメスフラスコに入れ、少量の水で溶解後、標線まで水を加える。
(注3)2mol/L 塩酸:水750mLに塩酸150mLをかき混ぜながら徐々に加える。
(注4)1/25mol/L チオ硫酸ナトリウム溶液:チオ硫酸ナトリウム20gを2Lのメスフラスコに入れ、少量の水で溶解後、標線まで水を加える。
(注5)デンプン指示薬:可溶性デンプン5gを水500mLに溶解し、これに塩化ナトリウム100gを溶解する。
The DE of starch syrup can be measured by the following method.
<< Measurement method of DE >>
Accurately weigh 2.5 g of the sample and dissolve in water to make 200 mL. Weigh 10 mL of this solution, add 10 mL of 1/25 mol / L iodine solution (Note 1) and 15 mL of 1/25 mol / L sodium hydroxide solution (Note 2), and leave it in the dark for 20 minutes. Next, 5 mL of 2 mol / L hydrochloric acid (Note 3) is added and mixed, and then titrated with a 1/25 mol / L sodium thiosulfate solution (Note 4). When the liquid turns slightly yellow near the end point of the titration, add 2 drops of starch indicator (Note 5) to continue the titration, and set the time point when the color of the liquid disappears as the end point of the titration. The blank value is obtained using water, and DE is obtained by the following equation 1.
(Note 1) 1/25 mol / L iodine solution: Put 20.4 g of potassium iodide and 10.2 g of iodine in a 2 L volumetric flask, dissolve in a small amount of water, and then add water up to the marked line.
(Note 2) 1/25 mol / L sodium hydroxide solution: Put 3.2 g of sodium hydroxide in a 2 L volumetric flask, dissolve in a small amount of water, and then add water up to the marked line.
(Note 3) 2 mol / L hydrochloric acid: Gradually add 150 mL of hydrochloric acid to 750 mL of water while stirring.
(Note 4) 1/25 mol / L sodium thiosulfate solution: Put 20 g of sodium thiosulfate in a 2 L volumetric flask, dissolve in a small amount of water, and then add water up to the marked line.
(Note 5) Starch indicator: Dissolve 5 g of soluble starch in 500 mL of water, and dissolve 100 g of sodium chloride in it.
本発明の飼料用展着剤は、還元水飴または水飴のみを含むものであってもよく、還元水飴または水飴以外の他の成分を含むものであってもよい。他の成分は、本発明の特徴を損なわない限り特に限定されるものではないが、例えば、グアーガム、CMC、アルギン酸ナトリウム、ポリアクリル酸ナトリウムなどの公知の展着剤、動物性油や植物性油、石油系合成油(例えば、流動パラフィンなど)などの油脂類、水やアルコールなどの溶媒等が挙げられる。 The spreader for feed of the present invention may contain only reduced starch syrup or starch syrup, or may contain other components other than reduced starch syrup or starch syrup. Other components are not particularly limited as long as they do not impair the characteristics of the present invention, and are, for example, known spreading agents such as guar gum, CMC, sodium alginate, sodium polyacrylate, animal oils and vegetable oils. , Oils and fats such as petroleum-based synthetic oil (for example, liquid paraffin), solvents such as water and alcohol, and the like.
本発明に係る飼料用展着剤において、還元水飴または水飴の固形分濃度は、飼料の形態や薬物の形態や用量などに応じて適宜設定することができる。一方、飼料における薬物展着の均一性をより向上させる観点、薬物の歩留りをより向上させる観点、薬物の展着量をより向上させる観点、あるいは薬物の溶出量をより抑制する観点からは、35質量%以上、35質量%超、40質量%以上、40質量%超、43質量%以上、43質量%超、45質量%以上、45質量%超、48質量%以上、48質量%超、50質量%以上、50質量%超、53質量%以上、53質量%超、55質量%以上、55質量%超、58質量%以上、58質量%超、60質量%以上、60質量%超、63質量%以上、63質量%超、65質量%以上、65質量%超、80質量%以下、75質量%以下または70質量%以下の固形分濃度を例示することができる。なお、液体における還元水飴または水飴の固形分濃度は、屈折計(糖度計)で測定することができる。 In the feed spreading agent according to the present invention, the solid content concentration of the reduced starch syrup or starch syrup can be appropriately set according to the form of the feed, the form and the dose of the drug, and the like. On the other hand, from the viewpoint of further improving the uniformity of drug spread in the feed, further improving the yield of the drug, further improving the spread amount of the drug, or further suppressing the elution amount of the drug, 35 Mass% or more, 35 mass% or more, 40 mass% or more, 40 mass% or more, 43 mass% or more, 43 mass% or more, 45 mass% or more, 45 mass% or more, 48 mass% or more, 48 mass% or more, 50 Mass% or more, 50 mass% or more, 53 mass% or more, 53 mass% or more, 55 mass% or more, 55 mass% or more, 58 mass% or more, 58 mass% or more, 60 mass% or more, 60 mass% or more, 63 Examples can be made of solid content concentrations of mass% or more, 63 mass% or more, 65 mass% or more, 65 mass% or more, 80 mass% or less, 75 mass% or less, or 70 mass% or less. The solid content concentration of the reduced starch syrup or starch syrup in the liquid can be measured with a refractometer (sugar content meter).
本発明において、還元水飴または水飴は、市販されているものをそのまま用いてもよく、当業者に公知の方法に従って製造して用いてもよい。 In the present invention, as the reduced starch syrup or starch syrup, commercially available starch syrup may be used as it is, or may be manufactured and used according to a method known to those skilled in the art.
還元水飴の公知の製造方法としては、原料となる水飴(原料糖)に水素を添加する還元反応を挙げることができる。水素添加による還元反応は、例えば、40〜75質量%の原料糖水溶液を、還元触媒と併せて高圧反応器中に仕込み、反応器中の水素圧を4.9〜19.6MPa、反応液温を70〜180℃として、混合攪拌しながら、水素の吸収が認められなくなるまで反応を行なえばよい。その後、還元触媒を分離し、イオン交換樹脂処理、必要であれば活性炭処理等で脱色脱塩した後、所定の濃度まで濃縮すれば、高濃度の還元水飴を作ることができる。 As a known method for producing reduced starch syrup, a reduction reaction in which hydrogen is added to starch syrup (raw sugar) as a raw material can be mentioned. In the reduction reaction by hydrogenation, for example, 40 to 75% by mass of a raw sugar aqueous solution is charged into a high-pressure reactor together with a reduction catalyst, the hydrogen pressure in the reactor is 4.9 to 19.6 MPa, and the reaction liquid temperature is The reaction may be carried out at 70 to 180 ° C. while mixing and stirring until hydrogen absorption is no longer observed. After that, the reduction catalyst is separated, decolorized and desalted by ion exchange resin treatment, if necessary, activated carbon treatment, etc., and then concentrated to a predetermined concentration to produce a high-concentration reduced starch syrup.
飼料用展着剤は、当業者に公知の方法により用いることができる。そのような方法としては、例えば、(i)飼料用展着剤を飼料に塗布してから薬物をまぶす方法や、(i)飼料用展着剤と薬物を混合してから、これと飼料とを混合する方法、(iii)飼料用展着剤、飼料および薬物を一斉にあるいは順次混合する方法などを例示することができる。混合は、手で行ってもよく、撹拌機などの機械で行ってもよい。当該方法により、本発明に係る表面に薬物が展着された固形飼料を得ることができる。 The spreader for feed can be used by a method known to those skilled in the art. Such methods include, for example, (i) applying a spreader for feed to the feed and then sprinkling the drug, or (i) mixing the spreader for feed and the drug, and then using this and the feed. (Iii), a spreader for feed, a method of mixing feed and drugs all at once or sequentially, and the like can be exemplified. The mixing may be performed by hand or by a machine such as a stirrer. By this method, a solid feed in which a drug is spread on the surface according to the present invention can be obtained.
以下、本発明について、各実施例に基づいて説明する。なお、本発明の技術的範囲は、これらの実施例によって示される特徴に限定されない。本実施例では、特段の記載のない限り、百分率(%)は質量%を示す。 Hereinafter, the present invention will be described based on each embodiment. The technical scope of the present invention is not limited to the features shown in these examples. In this embodiment, the percentage (%) indicates mass% unless otherwise specified.
<試料>
展着剤は、表1に示す市販の還元水飴、水飴、グァーガムおよびCMCを用いた。グァーガムおよびCMCは、水産飼料用の展着剤として従来より一般に使用されているものである。還元水飴および水飴(いずれも製品形態は固形分濃度70%または80%の液体)はそのまま、グァーガムおよびCMC(いずれも製品形態は粉末)は、1%となるよう水に溶解して水溶液の形態で用いた。表1において、還元水飴のDEは、原料糖のDEを示した。
As the spreading agent, commercially available reduced starch syrup, starch syrup, guar gum and CMC shown in Table 1 were used. Guar gum and CMC have traditionally been commonly used as spreading agents for marine feed. The reduced starch syrup and starch syrup (both product forms are liquids with a solid content concentration of 70% or 80%) remain as they are, and guar gum and CMC (both product forms are powders) are dissolved in water to a concentration of 1% to form an aqueous solution. Used in. In Table 1, the DE of the reduced starch syrup is the DE of the raw sugar.
また、薬物は、リボフラビン(形態:粉末、色:橙黄色、別名:ビタミンB2)(東京化成)を用いた。薬物の倍散剤(薬物を一定の倍率に薄める賦形剤)はデキストリン「パインデックス♯100」(形態:粉末、色:白色)(松谷化学工業)を用いた。飼料は「ハマチEP タフd12」(形状:エクストルーダーペレット、1粒の大きさ:φ10mm×10mm、色:焦げ茶色、組成:動物性飼料51%、穀類16%、植物性油かす類14%、その他19%)(フィード・ワン)を用いた。以下、本実施例では、この飼料を「ペレット」という場合がある。 The drug used was riboflavin (form: powder, color: orange-yellow, also known as vitamin B 2 ) (Tokyo Kasei). Dextrin "Paindex # 100" (form: powder, color: white) (Matsutani Chemical Industry Co., Ltd.) was used as a drug doubling agent (an excipient that dilutes the drug to a certain magnification). The feed is "Hamachi EP Tough d12" (Shape: Extruder pellets, 1 grain size: φ10 mm x 10 mm, Color: Dark brown, Composition: Animal feed 51%, Grains 16%, Vegetable oil residue 14%, Other 19%) (Feed One) was used. Hereinafter, in this embodiment, this feed may be referred to as "pellet".
<実施例1>有効成分の検討
(1)薬物展着飼料の作製
リボフラビンを1重量部に対し、デキストリンを4重量部の割合で混合し、これを粉体混合物とした。粉体混合物7.5g、ペレット300gおよび表1の各展着剤3gをポリ袋に入れ、ペレットに割れや欠けが生じないよう注意しながら1分間ポリ袋内で混合することにより、ペレット表面に薬物を展着させた。当該方法により薬物を展着させた飼料を薬物展着飼料とした。
<Example 1> Examination of active ingredient (1) Preparation of drug-spreading feed Riboflavin was mixed in a proportion of 1 part by weight and dextrin in a ratio of 4 parts by weight, and this was prepared as a powder mixture. Put 7.5 g of the powder mixture, 300 g of pellets, and 3 g of each spreading agent in Table 1 in a plastic bag, and mix them in the plastic bag for 1 minute while being careful not to crack or chip the pellets. The drug was spread. The feed on which the drug was spread by the method was used as the drug spread feed.
(2)均一性の評価
各展着剤を用いて作製した(1)の薬物展着飼料について、薬物の展着の様子を目視により評価した。飼料全量の写真を図1に、無作為に抽出した各飼料1粒の写真を図2に、それぞれ示す。また、各飼料から10粒ずつ無作為に抽出して、図3に示す評価点0〜4のいずれに該当するかを判断し、採点した。採点結果(10粒の平均値)を図4の棒グラフに示す。
(2) Evaluation of uniformity With respect to the drug spreading feed of (1) prepared using each spreading agent, the state of drug spreading was visually evaluated. A photograph of the total amount of feed is shown in FIG. 1, and a photograph of one randomly selected feed is shown in FIG. In addition, 10 grains were randomly sampled from each feed, and it was judged which of the evaluation points 0 to 4 shown in FIG. 3 was applicable, and the score was given. The scoring results (mean value of 10 grains) are shown in the bar graph of FIG.
図1および図2に示すように、展着剤としてCMCおよびグァーガムを用いた場合は大部分が薄い橙黄色であり、その中に、濃い橙黄色の箇所がまだらに存在していた。すなわち、大部分のペレットには少量の薬物が展着していて、その中に、多量の薬物に展着したペレットが比較的多数存在することが明らかになった。 As shown in FIGS. 1 and 2, when CMC and guar gum were used as the spreading agent, most of them were pale orange-yellow, and dark orange-yellow spots were present in the spots. That is, it was clarified that a small amount of drug was spread on most of the pellets, and a relatively large number of pellets spread on a large amount of drug were present in the pellets.
これに対して、展着剤として高糖化還元水飴、中糖化還元水飴(エスイー57、エスイー58)、低糖化還元水飴(エスイー30、エスイー100)および低糖化水飴を用いた場合は、大部分が中程度の濃さの橙黄色であり、その中に、濃い橙黄色の箇所がごく少数存在していた。特に、中糖化還元水飴、低糖化還元水飴および低糖化水飴を用いた場合は橙黄色の濃淡が小さく、低糖化還元水飴を用いた場合は橙黄色の濃淡が極めて小さかった。すなわち、薬物が多量に展着したペレットがごく少数存在するものの、ほとんどのペレットには中程度の量の薬物が展着していることが明らかになった。 On the other hand, when high saccharified reduced starch syrup, medium saccharified reduced starch syrup (SE 57, SE 58), low saccharified reduced starch syrup (SE 30, SE 100) and low saccharified starch syrup were used as spreading agents, most of them were used. It was moderately dark orange-yellow, and there were very few dark orange-yellow spots in it. In particular, when medium saccharified reduced starch syrup, low saccharified reduced starch syrup and low saccharified starch syrup were used, the shade of orange-yellow was small, and when low saccharified reduced starch syrup was used, the shade of orange-yellow was extremely small. That is, it was revealed that although there were only a few pellets in which a large amount of drug was spread, a moderate amount of drug was spread in most of the pellets.
また、図4に示すように、評価点は、CMCおよびグァーガムを用いた場合よりも、高糖化還元水飴、中糖化還元水飴(エスイー57、エスイー58)、低糖化還元水飴(エスイー30、エスイー100)および低糖化水飴を用いた場合の方が高かった。特に、中糖化還元水飴および低糖化水飴の評価点が高く、低糖化還元水飴の評価点が顕著に高かった。すなわち、CMCやグァーガムを用いた場合よりも還元水飴や水飴を用いた場合の方が、ペレットにおいて薬物が展着していない部位が少なく、展着の均一性が高かった。また、当該展着の均一性は、中糖化還元水飴または低糖化水飴で特に高く、低糖化還元水飴で顕著に高かった。 Further, as shown in FIG. 4, the evaluation points were higher saccharified reduced starch syrup, medium saccharified reduced starch syrup (SE 57, SE 58), and lower saccharified reduced starch syrup (SE 30, SE 100) than when CMC and guar gum were used. ) And low saccharified starch syrup were higher. In particular, the evaluation points of the medium saccharified reduced starch syrup and the low saccharified starch syrup were high, and the evaluation points of the low saccharified reduced starch syrup were remarkably high. That is, when the reduced starch syrup or starch syrup was used, there were fewer sites where the drug was not spread on the pellets than when CMC or guar gum was used, and the uniformity of spreading was higher. In addition, the uniformity of the spread was particularly high in the medium saccharified reduced starch syrup or the low saccharified starch syrup, and was remarkably high in the low saccharified reduced starch syrup.
以上の結果から、還元水飴および水飴は、市販の飼料用展着剤よりも均一に飼料に薬物を展着できることが明らかになった。 From the above results, it was clarified that the reduced starch syrup and starch syrup can spread the drug on the feed more uniformly than the commercially available feed spreading agent.
(3)展着量の評価
各展着剤を用いて作製した(1)の薬物展着飼料から10粒ずつ無作為に抽出して、写真を撮影した。画像解析ソフト「Adobe Photoshop CC2017」(アドビ システムズ)を用いて、写真画像における飼料をなげなわツールで1粒ずつ選択し、カラーチャンネルのヒストグラムを得て平均値(照度の平均値)を算出し、用いた展着剤ごとに10粒の平均値を求めた。その結果を図5の棒グラフに示す。ここで、ペレットは焦げ茶色、薬物は橙黄色であることから、薬物の展着量が多いほど、写真画像における飼料の照度は高くなると考えられる。すなわち、飼料における照度の平均値は、薬物の展着量の指標となる。
(3) Evaluation of spreading amount Ten grains were randomly extracted from the drug spreading feed of (1) prepared using each spreading agent, and photographs were taken. Using the image analysis software "Adobe Photoshop CC 2017" (Adobe Systems), select the feed in the photographic image one by one with the Nagenawa tool, obtain the histogram of the color channel, and calculate the average value (average value of illuminance). The average value of 10 tablets was calculated for each spreading agent used. The result is shown in the bar graph of FIG. Here, since the pellets are dark brown and the drug is orange-yellow, it is considered that the larger the spread amount of the drug, the higher the illuminance of the feed in the photographic image. That is, the average value of the illuminance in the feed is an index of the spread amount of the drug.
図5に示すように、照度の平均値は、CMCおよびグァーガムを用いた場合よりも、高糖化還元水飴、中糖化還元水飴(エスイー57、エスイー58)、低糖化還元水飴(エスイー30、エスイー100)および低糖化水飴を用いた場合の方が高かった。特に、中糖化還元水飴および低糖化水飴の照度が高く、低糖化還元水飴の照度が顕著に高かった。すなわち、CMCやグァーガムを用いた場合よりも還元水飴や水飴を用いた場合の方が、飼料における薬物の展着量が多かった。当該展着量は、中糖化還元水飴または低糖化水飴で特に多く、低糖化還元水飴で顕著に多かった。 As shown in FIG. 5, the average illuminance values are higher saccharified reduced starch syrup, medium saccharified reduced starch syrup (SE 57, SE 58), and lower saccharified reduced starch syrup (SE 30, SE 100) than when CMC and guar gum are used. ) And low saccharified starch syrup were higher. In particular, the illuminance of the medium saccharified reduced starch syrup and the low saccharified starch syrup was high, and the illuminance of the low saccharified reduced starch syrup was remarkably high. That is, the amount of drug spread in the feed was larger when reduced starch syrup or starch syrup was used than when CMC or guar gum was used. The spread amount was particularly large in the medium saccharified reduced starch syrup or the low saccharified starch syrup, and was remarkably large in the low saccharified reduced starch syrup.
この結果から、還元水飴および水飴は、市販の飼料用展着剤よりも多量に飼料に薬物を展着できることが明らかになった。すなわち、還元水飴および水飴は、高い展着力を有することが明らかになった。 From this result, it was clarified that the reduced starch syrup and starch syrup can spread the drug on the feed in a larger amount than the commercially available feed spreading agent. That is, it was clarified that reduced starch syrup and starch syrup have high spreading power.
(4)溶出量の評価
2L容量のビーカーに1500gの脱イオン水を入れ、撹拌機「スリーワンモーター BL300」(新東科学)および攪拌翼(アンカー翼)を用いて、60回転/分で水流を発生させた。ここに、(1)の薬物展着飼料(市販の飼料用展着剤はCMCを用いたもののみ)の全量(約310.5g)を投入した。投入から10秒、20秒、30秒、60秒、120秒および180秒後に同ビーカーから0.95mLの水を採取し、これをサンプル水とした。100μLのサンプル水をマイクロプレートリーダー「SpectraMax M2」(Molecular divice)に供して、445nmにおける吸光度(Abs.445)を測定した。その結果を図6〜9に示す。リボフラビンは波長440〜450nmに吸収スペクトルのピークを有することから、Abs.445はサンプル水におけるリボフラビン濃度の指標となる。すなわち、Abs.445の値が大きいほど、薬物展着飼料から溶出した薬物の量が多いと考えられる。
(4) Evaluation of elution amount Put 1500 g of deionized water in a beaker with a capacity of 2 L, and use a stirrer "Three One Motor BL300" (Shinto Kagaku) and a stirrer blade (anchor blade) to create a water flow at 60 rpm. Generated. Here, the total amount (about 310.5 g) of the drug spreading feed (1) (only commercially available feed spreading agents using CMC) was added. 0.95 mL of water was collected from the beaker 10 seconds, 20 seconds, 30 seconds, 60 seconds, 120 seconds and 180 seconds after the addition, and this was used as sample water. 100 μL of sample water was subjected to a microplate reader “SpectraMax M2” (Molecular divice), and the absorbance (Abs.445) at 445 nm was measured. The results are shown in FIGS. 6-9. Since riboflavin has an absorption spectrum peak at a wavelength of 440 to 450 nm, Abs.445 is an index of riboflavin concentration in sample water. That is, it is considered that the larger the value of Abs.445, the larger the amount of the drug eluted from the drug spreading feed.
図6および図7に示すように、高糖化還元水飴および中糖化還元水飴(エスイー57)を用いた場合のAbs.445は、CMCを用いた場合と同等であった。すなわち、高還元水飴や所定の糖組成の中還元水飴を用いた場合、薬物の溶出量は、市販の飼料用展着剤を用いた場合と同等の量に抑えられた。 As shown in FIGS. 6 and 7, Abs.445 when the highly saccharified reduced starch syrup and the medium saccharified reduced starch syrup (SE 57) were used was equivalent to that when CMC was used. That is, when a highly reduced starch syrup or a medium-reduced starch syrup having a predetermined sugar composition was used, the amount of drug eluted was suppressed to the same amount as when a commercially available feed spreading agent was used.
一方、図7、図8および図9に示すように、中糖化還元水飴(エスイー58)、低糖化還元水飴(エスイー30、エスイー100)および低糖化水飴を用いた場合のAbs.445は、CMCを用いた場合よりも小さかった。特に、低糖化還元水飴(エスイー100)のAbs.445が顕著に小さかった。すなわち、CMCやグァーガムを用いた場合よりも、所定の糖組成の中還元水飴や低糖化還元水飴あるいは低糖化水飴を用いた場合の方が、薬物の溶出量が少なかった。薬物の溶出量は、所定の糖組成の低糖化還元水飴で顕著に少なかった。 On the other hand, as shown in FIGS. 7, 8 and 9, Abs.445 in the case of using medium saccharified reduced starch syrup (SE 58), low saccharified reduced starch syrup (SE 30, SE 100) and low saccharified starch syrup is CMC. Was smaller than when was used. In particular, Abs.445 of low-saccharified reduced starch syrup (SE100) was remarkably small. That is, the amount of the drug eluted was smaller when the medium-reduced starch syrup, the low-saccharified reduced starch syrup, or the low-saccharified starch syrup having a predetermined sugar composition was used than when CMC or guar gum was used. The elution amount of the drug was remarkably small in the low-saccharified reduced starch syrup having a predetermined sugar composition.
これらの結果から、還元水飴および水飴は、水中においても優れた展着力を保持し、水中への薬物の溶出を抑制できることが明らかになった。当該薬物の溶出抑制作用は、低糖化還元水飴、低糖化水飴および所定の糖組成の中糖化還元水飴で高く、所定の糖組成の低糖化還元水飴で顕著に高いことが明らかになった。 From these results, it was clarified that the reduced starch syrup and starch syrup retain excellent spreading power even in water and can suppress the elution of the drug into water. It was clarified that the elution inhibitory effect of the drug was high in the low saccharified reduced starch syrup, the low saccharified starch syrup and the medium saccharified reduced starch syrup having a predetermined sugar composition, and remarkably high in the low saccharified reduced starch syrup having a predetermined sugar composition.
<実施例2>濃度の検討
(1)薬物展着飼料の作製
展着剤として、表1の低糖化還元水飴(エスイー30)の原液(固形分濃度70%)、これを脱イオン水で希釈して固形分濃度50%としたもの、および、固形分濃度35%としたものを用意し、それぞれ70%液、50%液および35%液とした。リボフラビンを1重量部に対し、デキストリンを4重量部の割合で混合し、粉体混合物とした。粉体混合物約7.5g、ペレット約300gおよび各展着剤約3gをポリ袋に入れ、ペレットに割れや欠けが生じないよう注意しながら1分間ポリ袋内で混合することにより、ペレット表面に薬物を展着させ、薬物展着飼料を作製した。
<Example 2> Examination of concentration (1) Preparation of drug spreading feed As a spreading agent, a stock solution (solid content concentration 70%) of the low saccharified reduced starch syrup (SE30) shown in Table 1 was diluted with deionized water. Then, one having a solid content concentration of 50% and one having a solid content concentration of 35% were prepared, and were used as a 70% solution, a 50% solution and a 35% solution, respectively. Riboflavin was mixed with 1 part by weight and dextrin at a ratio of 4 parts by weight to prepare a powder mixture. Approximately 7.5 g of powder mixture, approximately 300 g of pellets, and approximately 3 g of each spreading agent are placed in a plastic bag and mixed in the plastic bag for 1 minute while being careful not to crack or chip the pellets. The drug was spread to prepare a drug spreading feed.
(2)均一性の評価
(1)の薬物展着飼料について、薬物の展着の様子を目視により評価した。飼料全量の写真を図10に示す。また、各飼料から10粒ずつ無作為に抽出して、図3に示す評価点0〜4のいずれに該当するかを判断し、採点した。採点結果(10粒の平均値)を図11の棒グラフに示す。
(2) Evaluation of uniformity With respect to the drug spreading feed of (1), the state of drug spreading was visually evaluated. A photograph of the total amount of feed is shown in FIG. In addition, 10 grains were randomly sampled from each feed, and it was judged which of the evaluation points 0 to 4 shown in FIG. 3 was applicable, and the score was given. The scoring result (average value of 10 grains) is shown in the bar graph of FIG.
図10に示すように、橙黄色の濃淡の差は、70%液を用いた場合が最も小さく、次いで50%液が小さく、35%液が最も大きかった。また、図11に示すように、評価点は、70%液が最も高く、次いで50%液が高く、35%液が最も低かった。すなわち、低糖化還元水飴を固形分濃度50%あるいは70%で含有する展着剤を用いた場合に、薬物の展着の均一性が顕著に高かった。この結果から、展着剤における還元水飴または水飴の固形分濃度を50%以上とすることにより、より高い均一性をもって飼料に薬物を展着できることが明らかになった。 As shown in FIG. 10, the difference in shades of orange-yellow was the smallest when the 70% solution was used, followed by the 50% solution and the largest when the 35% solution was used. Further, as shown in FIG. 11, the evaluation points were highest in the 70% solution, followed by the 50% solution and the lowest in the 35% solution. That is, when a spreading agent containing low-saccharified reduced starch syrup at a solid content concentration of 50% or 70% was used, the uniformity of drug spreading was remarkably high. From this result, it was clarified that the drug can be spread on the feed with higher uniformity by setting the solid content concentration of the reduced starch syrup or starch syrup in the spreading agent to 50% or more.
(3)展着量の評価
[3−1]展着率
(1)の薬物展着飼料をポリ袋から出して重量を測定した。また、当該薬物展着飼料の作製に用いたペレット、展着剤および粉体混合物の重量の合計を算出し、これを仕込量とした。仕込量から薬物展着飼料の重量を減じた値を算出し、これを逸失量とした。逸失量は、用いた展着剤および粉体混合物のうち、ペレットに展着しなかった分の重量である。続いて、下記の式2により、展着率を算出した。展着率は、用いた展着剤および粉体混合物のうち、ペレットに展着した分の割合(すなわち、展着剤および粉体混合物の歩留り、あるいは、薬物の歩留まり)を示す。展着率の算出結果を表2および図12の棒グラフに示す。また、薬物展着飼料を取り出した後のポリ袋の様子を観察し、写真を撮影した。その結果を図13に示す。
式2:展着率(%)={(展着剤(g)+粉体混合物(g))−逸失量(g)/(展着剤(g)+粉体混合物(g))}×100
Equation 2: Spreading rate (%) = {(spreading agent (g) + powder mixture (g))-lost amount (g) / (spreading agent (g) + powder mixture (g))} × 100
表2および図12に示すように、展着率は、70%液を用いた場合が最も大きく、次いで50%液が大きく、35%液が最も小さかった。また、図13に示すように、薬物展着飼料を取り出した後のポリ袋に付着した薬物の量は、70%液を用いた場合が最も少なく、次いで50%液を用いた場合が少なく、35%液を用いた場合が最も多かった。 As shown in Table 2 and FIG. 12, the spreading rate was highest when the 70% solution was used, followed by the 50% solution and the 35% solution. Further, as shown in FIG. 13, the amount of the drug adhering to the plastic bag after taking out the drug spreading feed was the smallest when the 70% solution was used, followed by the case where the 50% solution was used. The most common case was the use of a 35% solution.
すなわち、低糖化還元水飴を固形分濃度50%あるいは70%で含有する展着剤を用いた場合に、ペレットに展着した薬物の量が顕著に大きく、付着しなかった薬物の量(薬物のロス)が顕著に少なかった。この結果から、展着剤における還元水飴または水飴の固形分濃度を50%以上とすることにより、より高い歩留りで飼料に薬物を展着できることが明らかになった。 That is, when a spreading agent containing low-saccharified reduced starch syrup at a solid content concentration of 50% or 70% was used, the amount of the drug spread on the pellet was remarkably large, and the amount of the drug that did not adhere (the amount of the drug). Loss) was significantly less. From this result, it was clarified that the drug can be spread on the feed with a higher yield by setting the solid content concentration of the reduced starch syrup or starch syrup in the spreading agent to 50% or more.
[3−2]照度
(1)の薬物展着飼料から10粒ずつ無作為に抽出して写真を撮影し、実施例1(3)に記載の方法により照度の平均値を求めた。その結果を図14の棒グラフに示す。
[3-2] 10 grains were randomly extracted from the drug spreading feed having the illuminance (1), and photographs were taken, and the average value of the illuminance was determined by the method described in Example 1 (3). The result is shown in the bar graph of FIG.
図14に示すように、照度の平均値は、70%液を用いた場合が最も高く、次いで50%液が高く、35%液が最も低かった。すなわち、低糖化還元水飴を固形分濃度50%あるいは70%で含有する展着剤を用いた場合に、ペレットへの薬物の展着量が顕著に大きかった。この結果から、展着剤における還元水飴または水飴の固形分濃度を50%以上とすることにより、より多量の薬物を飼料に展着できることが明らかになった。 As shown in FIG. 14, the average value of the illuminance was highest when the 70% solution was used, followed by the 50% solution and the lowest value when the 35% solution was used. That is, when a spreading agent containing low-saccharified reduced starch syrup at a solid content concentration of 50% or 70% was used, the amount of the drug spread on the pellets was remarkably large. From this result, it was clarified that a larger amount of drug can be spread on the feed by setting the solid content concentration of the reduced starch syrup or starch syrup in the spreading agent to 50% or more.
(4)溶出量の評価
(1)の薬物展着飼料について、実施例1(4)に記載の方法により吸光度(Abs.445)を測定した。その結果を図15に示す。
(4) Evaluation of Elution Amount The absorbance (Abs.445) of the drug-spread feed of (1) was measured by the method described in Example 1 (4). The result is shown in FIG.
図15に示すように、Abs.445は70%液を用いた場合が最も小さく、次いで50%液が小さく、35%液が最も大きかった。すなわち、低糖化還元水飴を固形分濃度50%あるいは70%で含有する展着剤を用いた場合に薬物の溶出量が顕著に少なかった。この結果から、展着剤における還元水飴または水飴の固形分濃度を50%以上とすることにより、水中への薬物の溶出を、より抑制できることが明らかになった。 As shown in FIG. 15, Abs.445 was the smallest when the 70% solution was used, followed by the 50% solution and the largest when the 35% solution was used. That is, when a spreading agent containing low-saccharified reduced starch syrup at a solid content concentration of 50% or 70% was used, the amount of drug eluted was remarkably small. From this result, it was clarified that the elution of the drug into water can be further suppressed by setting the solid content concentration of the reduced starch syrup or starch syrup in the spreading agent to 50% or more.
Claims (5)
単糖が1〜50質量%、
二糖が6〜55質量%、
三糖が7〜25質量%、
四糖が1〜10質量%、
五糖以上が1〜82質量%。 A feed spreading agent containing a reduced starch syrup having the following sugar composition or a starch syrup having the following sugar composition as an active ingredient;
1 to 50% by mass of monosaccharides,
Disaccharide is 6-55% by mass,
7-25% by mass of trisaccharide,
1-10% by mass of tetrasaccharide,
1-82% by mass of pentasaccharide or more.
単糖が1〜10質量%、
二糖が6〜12質量%、
三糖が7〜12質量%、
四糖が5〜10質量%、
五糖以上が64〜82質量%。 The feed spreading agent according to any one of claims 1 to 3, wherein the starch syrup or the reduced starch syrup has the following sugar composition.
1-10% by mass of monosaccharides,
6-12% by mass of disaccharide,
7-12% by mass of trisaccharide,
5-10% by mass of tetrasaccharide,
64-82% by mass of pentasaccharide or more.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019155260A JP2021029202A (en) | 2019-08-28 | 2019-08-28 | Spreader for feed, and solid feed on which medicine is spread by the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019155260A JP2021029202A (en) | 2019-08-28 | 2019-08-28 | Spreader for feed, and solid feed on which medicine is spread by the same |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021029202A true JP2021029202A (en) | 2021-03-01 |
Family
ID=74674158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019155260A Pending JP2021029202A (en) | 2019-08-28 | 2019-08-28 | Spreader for feed, and solid feed on which medicine is spread by the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2021029202A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6012939A (en) * | 1983-07-01 | 1985-01-23 | Kanegafuchi Chem Ind Co Ltd | Spreading drug composition and drug administration using it |
WO2009057653A1 (en) * | 2007-10-29 | 2009-05-07 | Nippon Suisan Kaisha, Ltd. | Parasite control agent for fish, and parasite control method for fish |
US20090235872A1 (en) * | 2008-03-19 | 2009-09-24 | Nevenka Filipi | Increased occupancy time pet chews |
JP2013223447A (en) * | 2012-04-20 | 2013-10-31 | Masuya:Kk | Adhesive for adhering salt grain to rice cracker, and method for producing rice cracker with salt grain |
KR20150072035A (en) * | 2013-12-19 | 2015-06-29 | 대한민국(관리부서 : 농림축산식품부 농림축산검역본부) | Vaccine bait and method for producing the same |
WO2018062246A1 (en) * | 2016-09-27 | 2018-04-05 | 日本水産株式会社 | Therapeutic agent for diseases mediated by microsporidia and myxosporea both parasitic in marine fishes |
JP2018183078A (en) * | 2017-04-25 | 2018-11-22 | 株式会社ヤマホ | Binder for food product, and food product |
-
2019
- 2019-08-28 JP JP2019155260A patent/JP2021029202A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6012939A (en) * | 1983-07-01 | 1985-01-23 | Kanegafuchi Chem Ind Co Ltd | Spreading drug composition and drug administration using it |
WO2009057653A1 (en) * | 2007-10-29 | 2009-05-07 | Nippon Suisan Kaisha, Ltd. | Parasite control agent for fish, and parasite control method for fish |
US20090235872A1 (en) * | 2008-03-19 | 2009-09-24 | Nevenka Filipi | Increased occupancy time pet chews |
JP2011515087A (en) * | 2008-03-19 | 2011-05-19 | ネステク ソシエテ アノニム | Pet chew increases occupancy time |
JP2013223447A (en) * | 2012-04-20 | 2013-10-31 | Masuya:Kk | Adhesive for adhering salt grain to rice cracker, and method for producing rice cracker with salt grain |
KR20150072035A (en) * | 2013-12-19 | 2015-06-29 | 대한민국(관리부서 : 농림축산식품부 농림축산검역본부) | Vaccine bait and method for producing the same |
WO2018062246A1 (en) * | 2016-09-27 | 2018-04-05 | 日本水産株式会社 | Therapeutic agent for diseases mediated by microsporidia and myxosporea both parasitic in marine fishes |
JP2018183078A (en) * | 2017-04-25 | 2018-11-22 | 株式会社ヤマホ | Binder for food product, and food product |
Non-Patent Citations (1)
Title |
---|
蓑田香奈子、栃尾巧、中村圭伸: "日本食を支える還元水あめの役割", 月刊フードケミカル, vol. 33号, JPN7022005659, 1 January 2017 (2017-01-01), JP, pages 35 - 39, ISSN: 0005073179 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9301540B2 (en) | Prebiotic composition and methods of making and using the same | |
DE2709390A1 (en) | ANTIBACTERIAL AGENT AND ITS USES | |
CN101578284A (en) | Agent for improving insulin resistance | |
US20140378412A1 (en) | Methods of making and using a ruminant gas reduction composition | |
KR101704858B1 (en) | Cashew nut shell oil having improved stability | |
JP6314647B2 (en) | Solid preparation | |
Forster | Some methods of binding prawn diets and their effects on growth and assimilation | |
FR2946882A1 (en) | GELIFIED VETERINARY SUSPENSION OF IRON | |
CN116133530A (en) | Use of mannooligosaccharide compositions for feeding crustaceans | |
KR101095795B1 (en) | ?-1,4-MANNOBlOSE-CONTAlNING COMPOSITION | |
JP2011057597A (en) | Hyperglycemic inhibitor | |
JP2021029202A (en) | Spreader for feed, and solid feed on which medicine is spread by the same | |
TWI791045B (en) | Use of an orally administered composition for promoting the growth of decapods | |
JP5099812B2 (en) | Blood sugar level rise inhibitor | |
EP2027862B1 (en) | Composition for enhancing immune function comprising zinc and a nigerooligosaccharide | |
US9351515B2 (en) | Nutritional composition and methods of making and using same | |
JP2002235084A (en) | Antioxidant | |
JP7262391B2 (en) | Fusobacterium and/or Stella bacteria count inhibitor | |
CN105254683B (en) | α type xylo-oligosaccharide and the preparation method and application thereof | |
EP1824347A1 (en) | Hydrophilic active principle pellets | |
EP1833307B1 (en) | Method for preparing pellets of hydrophilic active principle by extrusion | |
US5776483A (en) | Feed additive for ruminants | |
CN110384692B (en) | Application of carnosic acid and rosmarinic acid in preparation of medicine for preventing and treating type II diabetic nephropathy | |
JP2013188136A (en) | Cashew nut shell oil of improved stability | |
WO2019234349A1 (en) | Process for improving ruminal degradation of wheat straw |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220803 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20221118 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221207 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230531 |